CJC-1295
The pulse before sleep.
- Sizes available
- 2mg · 5mg · 10mg
- Lab certificate (COA)
- Supplier-published sample
· Research-grade only · Not for human consumption · 21+ ·
GH secretagogue. Commonly stacked with ipamorelin. Popular GH-axis compound.
Mechanism · Long-acting GHRH analog (typically the DAC variant). Half-life roughly 6-8 days.
Best for. Not for.
Best for
- GH-axis stimulation for sleep and recovery.
- Stack with ipamorelin (GHRP arm).
- Users on a weekly injection schedule (DAC variant).
Not for
- Children or adolescents (epiphyseal closure risk).
- Active malignancy or cancer history.
- Pregnancy, nursing, or uncontrolled diabetes.
- Active diabetic retinopathy progression.
Mechanism, dose, ramp, risk.
- Mechanism
- GHRH analogue. Stimulates endogenous GH pulses.Source · PEPVERA editorial
- Target dose
- 100 mcg / day at bedtime, subq.Source · PEPVERA editorial
- Ramp
- Begin full dose. 12-week cycle.Source · PEPVERA editorial
- Risks
- Sleep disturbance is a commonly reported side effect.Source · PEPVERA editorial
Compared to its siblings.
CJC-1295
GH secretagogue. Commonly stacked with ipamorelin. Popular GH-axis compound.
Pros
- · Weekly injection convenience versus daily MOD-GRF or sermorelin schedules.
- · Stronger sustained GH lift than the short-half-life GHRH analogs.
Cons
- · Non-physiologic baseline GH from DAC half-life, unlike pulsatile MOD-GRF.
- · Cleaner side-effect profile is on the GHRP arm (ipamorelin), not here.
- · No FDA historical track record (sermorelin has Geref legacy).
Ipamorelin
GHRP arm. Pure pulse with no cortisol or prolactin elevation.
Pros
- · Cleaner side-effect profile.
- · Stack synergy.
Cons
- · Daily injection burden.
See Ipamorelin →
MOD GRF 1-29
Non-DAC variant. Natural pulsatile pattern.
Pros
- · More physiologic pulse.
Cons
- · Multiple daily injections.
See MOD GRF 1-29 →
Sermorelin
First-generation GHRH (Geref). Short half-life.
Pros
- · FDA historical track record.
Cons
- · Short half-life, daily injection.
See Sermorelin →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 6 suppliers
| Supplier | Price | COA | Ships | |
|---|---|---|---|---|
| Pure Peptide UKUK | $12.95$6.47/mg · 2mg | In-house COA | 4 days | Out of stock |
| Pure Peptide UKUK | $32.5$6.50/mg · 5mg | In-house COA | 4 days | Out of stock |
| Ameano PeptidesUS | $38$7.60/mg · 5mg | Sample COA published | 2 days | |
| SwissChemsUS | $42.95$21.48/mg · 2mg | COA with shipment | 3 days | |
| Ascension PeptidesUS | $50$10.00/mg · 5mg | Sample COA published | 3 days | Out of stock |
| Verified PeptidesUS | $68$6.80/mg · 10mg | Sample COA published | 3 days |
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Risk
Sleep disturbance is a commonly reported side effect. These pass with discipline. They do not pass with bravado.
Source · PEPVERA editorialDiscipline
Begin full dose. 12-week cycle.
Source · PEPVERA editorialWellness
Hydrate. Eat protein. Sleep eight. Hold a dose for at least two weeks before ascending.
Anti-patterns
- · Do not pair with stimulants late in the day.
- · Do not break the cycle without a planned taper.
- · Do not exceed the dose to chase a deeper sleep response.
Crisis
If the ramp triggers severe anxiety, anhedonia, or persistent gastrointestinal disturbance, stop. Resume after two weeks at half the prior dose. The discipline is the slow climb.
Week 1
100 mcg / day at bedtime, subq.
Begin near site
Week 2–4
100 mcg / day at bedtime, subq.
Daily, rotate
Week 5–6
100 mcg / day at bedtime, subq.
Taper option
Week 7+
Maintenance
As needed
Draw 8 units.
0.2 mg = 0.08 mL at 2.50 mg/mL. 25.0 doses per vial.
repair · XIV · Ameano Peptides
CJC-1295 · 5mg